Views: 2 | Downloads: 0
Lysosomal cysteine cathepsins are proteolytic enzymes that take part in a number of
biological processes such as endosomal protein degradation, antigen processing, bone
remodeling. Besides their roles under normal physiological processes they are also
involved in a number of pathological processes such as cancer, arthritis and osteoporosis.
In these processes the cysteine cathepsins perform limited and unlimited proteolysis. The
current challenge in understanding of physiological roles of cysteine cathepsins is to gain
insight in the interactions with their natural protein substrates and their selection. Since
not much is known about endosomal cysteine cathepsins, we first made an attempt to
provide insight in the substrate binding of cathepsins V and L. By structural approaches
we tried to shed light on digestion data of natural samples analyzed by proteomics. This
work describes how we established an experimental platform to study interactions
between cysteine cathepsins and their natural substrates. We used presumably
catalytically inactive cathepsins and selected peptides. So far we were able to express,
crystallize and determine structures of catalytically inactive cathepsins L and V (C25S
mutation) as models for binding peptides within the active site.
The crystal structures of complexes of cathepsin V C25S with peptides and cathepsin
L C25S show peptide residues along the whole active site cleft from the S3 to S4' subsite,
confirming now also structurally that there are indeed seven residues interacting with the
active site of a papain-like enzyme as shown biochemically by the pioneering work of
Schechter and Berger back in 1968. This information was obtained by combining several
structures of complexes with peptides bound into the active site. The peptides were
designed on the basis of analysis of proteomic data of cathepsin V degradation pattern of
cell lysate. The structures showed peptides bound either in the non-primed or in the
primed side of the active site, but not in both. The structures revealed the binding of
peptides in the S3' and S4' subsites, whereas the subsequent residues are not in the
contact with the enzyme and are exposed to the solvent. The complexes of cathepsins V
C25S mutants which bind residues in the S3, S2 and S1 subsites indicated the existence
of low enzymatic activity of cathepsins. The final evidence for the remaining catalytic
activity came from the structure of cathepsin L C25S, which was cleaved during the twoweek
crystallization process. The crystal structure caught the cathepsin L protease –
cathepsin L substrate complex “in the act” after cleavage and before the final separation
of the two molecules. This analysis showed that the cysteine mutants only reduced the
catalytic activity of the enzymes to a level that is not detectable by fluorogenic
substrates. We suggest that given enough time all C25S and C25A active site mutants
can hydrolyze peptide bonds and that for the same reason also the complex of human
cathepsin L C25A mutant published by Adams-Cioaba et al. (2011) contained residues
only in the non-primed region.
In addition, we solved structures of cathepsin K in complex with different nitrile
inhibitors which show specific interactions at the S subsites of cathepsin K.